Page last updated: 2024-08-26

alpha-glutamyltryptophan and Acquired Immune Deficiency Syndrome

alpha-glutamyltryptophan has been researched along with Acquired Immune Deficiency Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aboulafia, D; Dezube, BJ; Gill, P; Lee, J; Noy, A; Scadden, DT; Tulpule, A; Walmsley, S1
Kisin, AV; Krugliak, IuL; Kurochkin, VK; Malekin, SI; Nosova, VM; RiakhovskiÄ­, VV1

Trials

1 trial(s) available for alpha-glutamyltryptophan and Acquired Immune Deficiency Syndrome

ArticleYear
Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Feb-10, Volume: 23, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Administration, Intranasal; Adult; Aged; AIDS-Related Opportunistic Infections; Angiogenesis Inhibitors; Anti-HIV Agents; CD4 Lymphocyte Count; Dipeptides; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Placebos; Remission Induction; Sarcoma, Kaposi; Self Administration; Viral Load

2005

Other Studies

2 other study(ies) available for alpha-glutamyltryptophan and Acquired Immune Deficiency Syndrome

ArticleYear
[Conjugates of 2',3'-didehydro-3'-deoxythymidine with thymogen. Synthesis and anti-HIV activity].
    Bioorganicheskaia khimiia, 1999, Volume: 25, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Dipeptides; HIV-1; Humans; Peptides; Stavudine

1999
AIDS-related Kaposi sarcoma trial is under way.
    The AIDS reader, 2001, Volume: 11, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Advertising; Angiogenesis Inhibitors; Clinical Trials, Phase III as Topic; Dipeptides; Humans; Sarcoma, Kaposi

2001